Skip to main content
Erschienen in: Digestive Diseases and Sciences 6/2022

01.05.2021 | Original Article

Impact of Readmission for Variceal Upper Gastrointestinal Bleeding: A Nationwide Analysis

verfasst von: Simcha Weissman, Sachit Sharma, Muhammad Aziz, Dean Ehrlich, Megan Perumpail, Michael Sciarra, James H. Tabibian

Erschienen in: Digestive Diseases and Sciences | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Variceal upper gastrointestinal bleeding (VUGIB) is a common and potentially lethal complication of cirrhosis. Population-based data regarding hospital readmission and other outcomes in VUGIB are limited.

Aim

In a large United States database of patients with VUGIB, we evaluated readmission rates, mortality rates, healthcare resource consumption, and identified predictors of readmission.

Methods

The 2017 Nationwide Readmission Database using ICD-10 codes was used to identify all adult patients admitted for VUGIB. Primary outcomes were 30- and 90-day readmission rates. Secondary outcomes included mortality, healthcare resource consumption, and predictors of readmission. Multivariate regression analysis was used to adjust for potential confounders.

Results

In 2017, there were 26,498 patients with VUGIB discharged from their index hospitalization, and 24.7% were readmitted (all-cause) within 30-days and 41.5% within 90-days. Recurrent VUGIB accounted for 26.7% and 28.9% of 30- and 90-day readmissions, respectively. Compared to index admissions, 30-day readmissions were associated with higher mortality (4.3% vs. 6.4%, p < 0.01), increased mean hospital length of stay (5.6 days vs. 4.5 days, p < 0.01), and charges ($65,984 vs. $53,784, p < 0.01), with similar findings in 90-day readmissions. Factors associated with 30-day readmission included end-stage renal disease (HR 1.2, p < 0.05), chronic kidney disease (HR 1.31, p < 0.01), and acute kidney injury (HR 1.14, p < 0.05).

Conclusion

Based on a nationwide cohort of hospitalized VUGIB patients, 25% were readmitted within 30-days and 42% within 90-days. Readmission was associated with increased mortality and healthcare consumption compared to the index admission. Additionally, acute and chronic renal injury were predictors of patients at high-risk for readmission.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–938.CrossRef Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–938.CrossRef
2.
Zurück zum Zitat Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362:823–832.CrossRef Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362:823–832.CrossRef
3.
Zurück zum Zitat Lim N, Desarno MJ, Lidofsky SD, Ganguly E. Hospitalization for variceal hemorrhage in an era with more prevalent cirrhosis. World J Gastroenterol. 2014;20:11326–11332.CrossRef Lim N, Desarno MJ, Lidofsky SD, Ganguly E. Hospitalization for variceal hemorrhage in an era with more prevalent cirrhosis. World J Gastroenterol. 2014;20:11326–11332.CrossRef
4.
Zurück zum Zitat Viviane A, Alan BN. Estimates of costs of hospital stay for variceal and nonvariceal upper gastrointestinal bleeding in the United States. Value Health. 2008;11:1–3.CrossRef Viviane A, Alan BN. Estimates of costs of hospital stay for variceal and nonvariceal upper gastrointestinal bleeding in the United States. Value Health. 2008;11:1–3.CrossRef
5.
Zurück zum Zitat Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:652–659.CrossRef Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:652–659.CrossRef
6.
Zurück zum Zitat Jamal MM, Samarasena JB, Hashemzadeh M. Decreasing in-hospital mortality for oesophageal variceal hemorrhage in the USA. Eur J Gastroenterol Hepatol. 2008;20:947–955.CrossRef Jamal MM, Samarasena JB, Hashemzadeh M. Decreasing in-hospital mortality for oesophageal variceal hemorrhage in the USA. Eur J Gastroenterol Hepatol. 2008;20:947–955.CrossRef
7.
Zurück zum Zitat Stokkeland K, Brandt L, Ekbom A et al. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969–2002. Hepatology 2006;43:500–505.CrossRef Stokkeland K, Brandt L, Ekbom A et al. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969–2002. Hepatology 2006;43:500–505.CrossRef
8.
Zurück zum Zitat Bilal M, Abougergi MS, Tayyem O, Parupudi S, Rockey DC. Thirty-Day Readmission After Esophageal Variceal Hemorrhage and its Impact on Outcomes in the United States. J Clin Gastroenterol. 2020;54:477–483.CrossRef Bilal M, Abougergi MS, Tayyem O, Parupudi S, Rockey DC. Thirty-Day Readmission After Esophageal Variceal Hemorrhage and its Impact on Outcomes in the United States. J Clin Gastroenterol. 2020;54:477–483.CrossRef
10.
Zurück zum Zitat Krige JE, Kotze UK, Bornman PC, Shaw JM, Klipin M. Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices. Ann Surg. 2006;244:764–770.CrossRef Krige JE, Kotze UK, Bornman PC, Shaw JM, Klipin M. Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices. Ann Surg. 2006;244:764–770.CrossRef
11.
Zurück zum Zitat El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J gastroenterol. 2000;2000:3566–3573.CrossRef El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J gastroenterol. 2000;2000:3566–3573.CrossRef
12.
Zurück zum Zitat Chalasani N, Kahi C, Francois F et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol. 2003;98:653–659.CrossRef Chalasani N, Kahi C, Francois F et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol. 2003;98:653–659.CrossRef
13.
14.
Zurück zum Zitat Gado Ahmed, Ebeid Basel, Abdelmohsen Aida, Gado Tarek, Axon Anthony. Endoscopy audit over 10 years in a community hospital in Egypt. Alex J Med. 2018;54:207–214. Gado Ahmed, Ebeid Basel, Abdelmohsen Aida, Gado Tarek, Axon Anthony. Endoscopy audit over 10 years in a community hospital in Egypt. Alex J Med. 2018;54:207–214.
15.
Zurück zum Zitat Wang T, Qian B, Ryou M, Abougergi MS. Validation of ICD-10 and CPT Codes to Identify Acute Esophageal Variceal Hemorrhage and Band Ligation among Patients with Liver Cirrhosis. J Clin Gastroenterol Hepatol. 2020;4:225. Wang T, Qian B, Ryou M, Abougergi MS. Validation of ICD-10 and CPT Codes to Identify Acute Esophageal Variceal Hemorrhage and Band Ligation among Patients with Liver Cirrhosis. J Clin Gastroenterol Hepatol. 2020;4:225.
17.
Zurück zum Zitat Barkun AN, Almadi M, Kuipers EJ et al. Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the international consensus group. Ann Intern Med. 2019;171:805–822.CrossRef Barkun AN, Almadi M, Kuipers EJ et al. Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the international consensus group. Ann Intern Med. 2019;171:805–822.CrossRef
18.
Zurück zum Zitat Hung T, Tsai C, Hsieh Y et al. Effect of renal impairment on mortality of patients with cirrhosis and spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2012;10:677–681.CrossRef Hung T, Tsai C, Hsieh Y et al. Effect of renal impairment on mortality of patients with cirrhosis and spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2012;10:677–681.CrossRef
19.
Zurück zum Zitat Hsieh Y, Lee K, Chen P et al. Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding. J Gastroenterol Hepatol. 2017;32:1859–1866.CrossRef Hsieh Y, Lee K, Chen P et al. Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding. J Gastroenterol Hepatol. 2017;32:1859–1866.CrossRef
20.
Zurück zum Zitat Carbonell N, Pauwels A, Serfaty L et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:1–8.CrossRef Carbonell N, Pauwels A, Serfaty L et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:1–8.CrossRef
Metadaten
Titel
Impact of Readmission for Variceal Upper Gastrointestinal Bleeding: A Nationwide Analysis
verfasst von
Simcha Weissman
Sachit Sharma
Muhammad Aziz
Dean Ehrlich
Megan Perumpail
Michael Sciarra
James H. Tabibian
Publikationsdatum
01.05.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 6/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07011-4

Weitere Artikel der Ausgabe 6/2022

Digestive Diseases and Sciences 6/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.